{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:27:08Z","timestamp":1707524828948},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,18]]},"DOI":"10.7759\/cureus.33952","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:27:25Z","timestamp":1674113245000},"source":"Crossref","is-referenced-by-count":0,"title":["Guillain-Barr\u00e9 Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV"],"prefix":"10.7759","author":[{"given":"Lanka","family":"Wijekoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chamara","family":"Sarathchandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sisira","family":"Siribaddana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26143","article-title":"Guillain-Barr\u00e9 syndrome following ChAdOx1-S\/nCoV-19 Vaccine","volume":"90","author":"Maramattom BV","year":"2021","unstructured":"Maramattom BV, Krishnan P, Paul R, Padmanabhan S, Cherukudal Vishnu Nampoothiri S, Syed AA, Mangat HS. Guillain-Barr\u00e9 syndrome following ChAdOx1-S\/nCoV-19 Vaccine. Ann Neurol. 2021, 90:312-4. 10.1002\/ana.26143","journal-title":"Ann Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.935275","article-title":"Guillain-Barr\u00e9 syndrome after Ad26.COV2.S vaccination","volume":"23","author":"Thant HL","year":"2022","unstructured":"Thant HL, Morgan R, Paese MM, Persaud T, Diaz J, Hurtado L. Guillain-Barr\u00e9 syndrome after Ad26.COV2.S vaccination. Am J Case Rep. 2022, 23:e935275. 10.12659\/AJCR.935275","journal-title":"Am J Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcac102","article-title":"Guillain-Barr\u00e9 syndrome after BNT162b2 (Pfizer-BioNTec) vaccination","volume":"115","author":"Takahashi K","year":"2022","unstructured":"Takahashi K, Tomoda Y, Kadena S, Kanbayashi T, Kobayashi S, Kato R. Guillain-Barr\u00e9 syndrome after BNT162b2 (Pfizer-BioNTec) vaccination. QJM. 2022, 115:331-3. 10.1093\/qjmed\/hcac102","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-249749","article-title":"Rare occurrence of Guillain-Barr\u00e9 syndrome after Moderna vaccine","volume":"15","author":"Bijoy George T","year":"2022","unstructured":"Bijoy George T, Kainat A, Pachika PS, Arnold J. Rare occurrence of Guillain-Barr\u00e9 syndrome after Moderna vaccine. BMJ Case Rep. 2022, 15:10.1136\/bcr-2022-249749","journal-title":"BMJ Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2045153","article-title":"Post COVID-19 vaccination Guillain-Barre syndrome: three cases","volume":"18","author":"Tabatabaee S","year":"2022","unstructured":"Tabatabaee S, Rezania F, Alwedaie SM, Malekdar E, Badi Z, Tabatabaei SM, Mirzaasgari Z. Post COVID-19 vaccination Guillain-Barre syndrome: three cases. Hum Vaccin Immunother. 2022, 18:2045153. 10.1080\/21645515.2022.2045153","journal-title":"Hum Vaccin Immunother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome","volume":"6","author":"van Koningsveld R","year":"2007","unstructured":"van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome. Lancet Neurol. 2007, 6:589-94. 10.1016\/S1474-4422(07)70130-8","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard SE","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FA, et al.. Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019, 15:671-83. 10.1038\/s41582-019-0250-9","journal-title":"Nat Rev Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial","volume":"326","author":"Al Kaabi N","year":"2021","unstructured":"Al Kaabi N, Zhang Y, Xia S, et al.. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA. 2021, 326:35-45. 10.1001\/jama.2021.8565","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord S","year":"2021","unstructured":"Pavord S, Scully M, Hunt BJ, et al.. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med. 2021, 385:1680-9. 10.1056\/NEJMoa2109908","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2821","article-title":"Myocarditis occurring after immunization with mRNA-Based COVID-19 vaccines","volume":"6","author":"Shay DK","year":"2021","unstructured":"Shay DK, Shimabukuro TT, DeStefano F. Myocarditis occurring after immunization with mRNA-Based COVID-19 vaccines. JAMA Cardiol. 2021, 6:1115-7. 10.1001\/jamacardio.2021.2821","journal-title":"JAMA Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.08.013","article-title":"Side effects and perceptions following Sinopharm COVID-19 vaccination","volume":"111","author":"Saeed BQ","year":"2021","unstructured":"Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following Sinopharm COVID-19 vaccination. Int J Infect Dis. 2021, 111:219-26. 10.1016\/j.ijid.2021.08.013","journal-title":"Int J Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200932040-00005","article-title":"Vaccines and Guillain-Barr\u00e9 syndrome","volume":"32","author":"Haber P","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barr\u00e9 syndrome. Drug Saf. 2009, 32:309-23. 10.2165\/00002018-200932040-00005","journal-title":"Drug Saf"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg B","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014, 10:469-82. 10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-022-09316-6","article-title":"Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review","volume":"70","author":"Abolmaali M","year":"2022","unstructured":"Abolmaali M, Rezania F, Behnagh AK, Hamidabad NM, Gorji A, Mirzaasgari Z. Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review. Immunol Res. 2022, 70:752-64. 10.1007\/s12026-022-09316-6","journal-title":"Immunol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.32598\/bcn.2021.3565.1","article-title":"Guillain-Barre syndrome and COVID-19 vaccine: a report of nine patients","volume":"12","author":"Karimi N","year":"2021","unstructured":"Karimi N, Boostani R, Fatehi F, et al.. Guillain-Barre syndrome and COVID-19 vaccine: a report of nine patients. Basic Clin Neurosci. 2021, 12:703-10. 10.32598\/bcn.2021.3565.1","journal-title":"Basic Clin Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.6451","article-title":"Guillain-Barr\u00e9 syndrome following COVID-19 vaccine: a\u00a0case report","volume":"10","author":"Fakhari MS","year":"2022","unstructured":"Fakhari MS, Poorsaadat L, Mahmoodiyeh B. Guillain-Barr\u00e9 syndrome following COVID-19 vaccine: a\u00a0case report. Clin Case Rep. 2022, 10:e6451. 10.1002\/ccr3.6451","journal-title":"Clin Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5254-8","article-title":"A Guillain-Barr\u00e9 syndrome variant with prominent facial diplegia","volume":"256","author":"Susuki K","year":"2009","unstructured":"Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barr\u00e9 syndrome variant with prominent facial diplegia. J Neurol. 2009, 256:1899-905. 10.1007\/s00415-009-5254-8","journal-title":"J Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12081046","article-title":"Bilateral facial weakness with distal paresthesia following COVID-19 vaccination: a scoping review for an atypical variant of Guillain-Barr\u00e9 syndrome","volume":"12","author":"Kim YH","year":"2022","unstructured":"Kim YH, Kim JE, Yoon BA, Kim JK, Bae JS. Bilateral facial weakness with distal paresthesia following COVID-19 vaccination: a scoping review for an atypical variant of Guillain-Barr\u00e9 syndrome. Brain Sci. 2022, 12:1046. 10.3390\/brainsci12081046","journal-title":"Brain Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31820d8b40","article-title":"Guillain-Barre syndrome and SIADH","volume":"76","author":"Saifudheen K","year":"2011","unstructured":"Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology. 2011, 76:701-4. 10.1212\/WNL.0b013e31820d8b40","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/130395-guillain-barr-syndrome-following-the-first-dose-of-inactivated-sars-cov-2-vaccine-bbibp-corv","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:54Z","timestamp":1707508074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/130395-guillain-barr-syndrome-following-the-first-dose-of-inactivated-sars-cov-2-vaccine-bbibp-corv"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.33952","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,18]]}}}